ClinVar Miner

Submissions for variant NM_001113378.1(FANCI):c.3041G>A (p.Cys1014Tyr) (rs140404896)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000778450 SCV000914698 likely pathogenic Fanconi anemia, complementation group I 2017-09-06 criteria provided, single submitter clinical testing The FANCI c.3041G>A (p.Cys1014Tyr) missense variant has been reported in three studies in which it is found in a total of six individuals including in three with Fanconi anemia, one in a homozygous state and two in a compound heterozygous state with a second null allele. One of the compound heterozygous individuals was also diagnosed with the VACTERL phenotype. The p.Cys1014Tyr variant was also reported in a heterozygous state in three individuals, one with breast cancer and two with prostate cancer (Ameziane et al. 2012; Mantere et al. 2015; Savage et al. 2016). The p.Cys1014Tyr variant was reported in four of 1365 controls in a heterozygous state and is reported at a frequency of 0.000853 in the European (Finnish) population of the Genome Aggregation Database. Based on the evidence, the p.Cys1014Tyr variant is classified as likely pathogenic for Fanconi anemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.